“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer

€3.03

SKU: product-article-11279 Category: General

Description
Reviews (0)

Description

Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer

Reviews

There are no reviews yet.

Be the first to review “Article: Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer”

You must be logged in to post a review.

Top

Article: Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Highlights in digestive oncology

Article: Highlights in respiratory oncology

Article: INTRODUCTION